Back to company

Evosep ApS: Financial statements 2018

CVR: 37510068

Evosep ApS (CVR 37510068) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 2,509,519 and a net result of DKK -4,951,102 compared with DKK -8,613,473 the year before. Equity amounted to DKK 22,510,339. The solvency ratio was 91.2%.

Gross Profit
2,509,519 kr.
Profit/Loss
-4,951,102 kr.
Equity
22,510,339 kr.
Total Assets
24,685,964 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2018-2.5 mio.-5 mio.22.5 mio.-
2017--2.7 mio.-8.6 mio.7.2 mio.-
2016--1.2 mio.-4.2 mio.7.9 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on Evosep ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2018

Evosep ApS: The 2017 annual report is outApr 30, 2018

Evosep ApS has published its annual report for 2017. Gross profit came to DKK -2,722,228, and the net result was DKK -8,613,473.

About Evosep ApS

Evosep ApS is a Danish company of the type Anpartsselskab based in Odense M, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Omics Ready Biosystems ApS. The management consists of Morten Bern. The company is owned by Paradigm BidCo ApS. The company has 16 employees. In 2025, the company reported a gross profit of DKK 72,369,000 and a net result of DKK -221,637,000 compared with DKK -2,613,000 the year before. Equity amounted to DKK 154,548,000.